Petrovax has announced encouraging findings from the Long-CoV-III-21 trial, a randomised, double-blind, placebo-controlled study evaluating the efficacy and safety of…
The oncology market, already huge, is set for major expansion. According to analysis from GlobalData, it will generate trillions of…
Despite inflationary pressures and ongoing challenges in the geopolitical landscape, expectations are high regarding the biopharmaceutical industry’s growth prospects. A…
Small cell lung cancer is a fast-growing and aggressive subtype of lung cancer, accounting for approximately 10-15% of all lung…
Randomization is crucial to reduce selection bias between participants in clinical trials. eClinical data platforms should make randomization processes more…
With the world facing threats from new and emerging infectious diseases, the ability to rapidly ramp up production of essential…
The latest webinar from EMIS, a leading healthcare technology provider, showcased its Pathway platform—a robust tool designed to improve the…
Clinical trials are the testing ground for new therapies. Ensuring the supply chains supporting these therapies remain robust is a…
As smaller, leaner organisations that must utilise resources carefully, biotechs face unique challenges as they enter clinical trials. These challenges…
Buffer management is a fundamental yet often neglected area of biopharmaceutical production. The demand for highly flexible multi-product systems is…
